Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
SpringWorks Therapeutics Inc (SpringWorks Therapeutics) is a commercial-stage biopharmaceutical company that develops therapies for rare tumors. The company's pipleine products include Nirogacestat is a gamma secretase inhibitor for the treatment of adult desmoid tumors, pediatric desmoid tumors, ovarian granulosa cell tumors, and relapsed/refractory multiple myeloma; Mirdametinib, a MEK inhibitor which treats adult and pediatric nf1-associated plexiform neurofibromas and pediatric low-grade gliomas; SW-682, a TEAD Inhibitor for hippo mutant tumors; and SW-3431, PP2A Activator which targets rare uterine cancers.SpringWorks is headquartered in Stamford, Connecticut, the US.
Headquarters
United States of America
Address
100 Washington Blvd, Stamford, Connecticut, 06902-9302
Website
www.springworkstx.com
Telephone
1 203 8839490
No of Employees
368
Industry
Pharmaceuticals and Healthcare
Revenue (2024)
$191.6M
SpringWorks Therapeutics Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| Nirogacestat: |
| Adult desmoid Tumors |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Ownership Changes | In July, the company was acquired by Merck KGaA, a science and technology company. |
| 2025 | Contracts/Agreements | In February, the company partnered with Jennifer Fisher to accelerate understanding of desmoid tumors. |
| 2025 | Regulatory Approval | In February, the company received approval from the U.S. Food and Drug Administration for GOMEKLI (mirdametinib), SpringWorks’ MEK inhibitor, for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas not amenable to complete resection. |
Competitor Comparison
| Key Parameters | SpringWorks Therapeutics Inc | Tonix Pharmaceuticals Holding Corp | Azevan Pharmaceuticals Inc | BetaCat Pharmaceuticals Inc | BioXcel Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Stamford | Berkeley Heights | Bethlehem | Houston | Branford |
| State/Province | Connecticut | New Jersey | Pennsylvania | Texas | Connecticut |
| No. of Employees | 368 | 142 | - | - | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer